NNelo Trade
← Back to Market News
September 23, 2026 at 08:23 PM UTC

Jazz Pharmaceuticals plc reports material agreement in SEC 8-K

Jazz Pharmaceuticals plc filed an 8-K covering a material definitive agreement and a direct financial obligation. Nelo verified the filing topics against the primary SEC document. This is a company disclosure filed with the SEC, not an SEC enforcement action.

Official source: U.S. Securities and Exchange Commission

Official source published: September 23, 2026 at 08:15 PM UTC

Open official source
Jazz Pharmaceuticals plc reports material agreement in SEC 8-K | Nelo Trade